(Q48361936)

English

Nigrostriatal dopaminergic activities in dementia with Lewy bodies in relation to neuroleptic sensitivity: comparisons with Parkinson's disease.

scientific article published in October 1998

Nigrostriatal dopaminergic activities in dementia with lewy bodies in relation to neuroleptic sensitivity: comparisons with parkinson’s disease

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9798081%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

Nigrostriatal dopaminergic activities in dementia with Lewy bodies in relation to neuroleptic sensitivity: comparisons with Parkinson's disease (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9798081%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

0 references

Parkinson's disease

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

dementia with Lewy bodies

1 reference

based on heuristic

inferred from title

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9798081%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

author name string

M A Piggott

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9798081%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

E K Perry

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9798081%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

E F Marshall

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9798081%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

M Johnson

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9798081%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

H L Melrose

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9798081%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

J A Court

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9798081%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

S Lloyd

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9798081%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

A Fairbairn

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9798081%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

A Brown

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9798081%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

P Thompson

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9798081%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

R H Perry

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9798081%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

language of work or name

0 references

publication date

1 October 1998

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9798081%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

Biological Psychiatry

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9798081%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

44

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9798081%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9798081%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

765-774

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9798081%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

Changes in brain catecholamines and dopamine uptake sites at different stages of MPTP parkinsonism in monkeys.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900127-9

7 January 2021

Striatal neurons express increased level of dopamine D2 receptor mRNA in response to haloperidol treatment: a quantitative in situ hybridization study.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900127-9

7 January 2021

[3H]spiperone binding, dopamine and HVA concentrations in Parkinson's disease and supranuclear palsy

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900127-9

7 January 2021

How "malignant" is the neuroleptic malignant syndrome?

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900127-9

7 January 2021

Distribution of catecholamine uptake sites in human brain as determined by quantitative [3H] mazindol autoradiography

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900127-9

7 January 2021

The effect of haloperidol on D2 dopamine receptor subtype mRNA levels in the brain

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900127-9

7 January 2021

Differential effect of chronic dopaminergic treatment on dopamine D1 and D2 receptors in the monkey brain in MPTP-induced parkinsonism

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900127-9

7 January 2021

Distribution of D1- and D2-dopamine receptors, and dopamine and its metabolites in the human brain

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900127-9

7 January 2021

The Lewy body variant of Alzheimer's disease: a clinical and pathologic entity

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900127-9

7 January 2021

Dopamine in the basal ganglia. Its role and therapeutic implications (including the clinical use of L-DOPA).

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900127-9

7 January 2021

Organization of dopamine D1 and D2 receptors in human striatum: receptor autoradiographic studies in Huntington's disease and schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900127-9

7 January 2021

Uneven pattern of dopamine loss in the striatum of patients with idiopathic Parkinson's disease. Pathophysiologic and clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900127-9

7 January 2021

Quantitative autoradiography of striatal dopamine D1, D2 and re-uptake sites in rats with vacuous chewing movements

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900127-9

7 January 2021

Postmortem stability of monoamines, their metabolites, and receptor binding in rat brain regions

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900127-9

7 January 2021

Neurotransmitters in basal ganglia and cortex of Alzheimer's disease with and without Lewy bodies

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900127-9

7 January 2021

Neuroleptic sensitivity in patients with senile dementia of Lewy body type

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900127-9

7 January 2021

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900127-9

7 January 2021

Differential vulnerability of primate caudate-putamen and striosome-matrix dopamine systems to the neurotoxic effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900127-9

7 January 2021

Neuroleptic malignant syndrome: a study of CSF monoamine metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900127-9

7 January 2021

Extrinsic connections of the basal ganglia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900127-9

7 January 2021

Senile dementia of Lewy body type. A clinically and neuropathologically distinct form of Lewy body dementia in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900127-9

7 January 2021

Monoaminergic activities in Lewy body dementia: relation to hallucinosis and extrapyramidal features.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900127-9

7 January 2021

Lesions of mouse striatum induced by 6-hydroxydopamine differentially alter the density, rate of synthesis, and level of gene expression of D1 and D2 dopamine receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900127-9

7 January 2021

Positron emission tomography demonstrates dopamine D2 receptor supersensitivity in the striatum of patients with early Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900127-9

7 January 2021

Modulation by GTP of basal and agonist-stimulated striatal adenylate cyclase activity following chronic blockade of D1 and D2 dopamine receptors: involvement of G proteins in the development of receptor supersensitivity.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900127-9

7 January 2021

Autoradiographic analysis of regional alterations in brain receptors following chronic administration and withdrawal of typical and atypical neuroleptics in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900127-9

7 January 2021

Regional differences in chronic neuroleptic effects on extracellular dopamine activity

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900127-9

7 January 2021

Dopamine receptors and transporters in Parkinson's disease and schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900127-9

7 January 2021

Human brain D1 and D2 dopamine receptors in schizophrenia, Alzheimer's, Parkinson's, and Huntington's diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900127-9

7 January 2021

EFFECT OF CHLORPROMAZINE OR HALOPERIDOL ON FORMATION OF 3METHOXYTYRAMINE AND NORMETANEPHRINE IN MOUSE BRAIN.

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900127-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Receptors in the basal ganglia

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2898%2900127-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0006-3223(98)00127-9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9798081%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9798081%20AND%20SRC:MED&resulttype=core&format=json

6 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48361936&oldid=2151043565"